Literature DB >> 9131761

Characterizing exposure-disease association in human populations using the Lorenz curve and Gini index.

W C Lee1.   

Abstract

To characterize exposure-disease association in human populations, epidemiologists have long relied upon such indices as "relative risk' and/or 'attributable risk'. However, the relative risk is not in a common unit which permits comparison across different exposures or different diseases and the attributable risk may not adequately catch and describe the variation of disease risks in populations. The present paper discusses the possibility of using the summary index of the Lorenz curve, the Gini index, as an alternative measure of exposure-disease association. It is found that this index can be interpreted in several ways (as the coefficient of deviation in disease risk or relative risk, the information content of the exposure, the impact fraction of an exposure-lowering programme, and the averaged impact fraction) and is a promising alternative as a fundamental measure in epidemiology. Further studies are warranted to investigate its statistical properties.

Entities:  

Mesh:

Year:  1997        PMID: 9131761     DOI: 10.1002/(sici)1097-0258(19970415)16:7<729::aid-sim491>3.0.co;2-a

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  20 in total

1.  State-level income inequality and individual mortality risk: a prospective, multilevel study.

Authors:  K Lochner; E Pamuk; D Makuc; B P Kennedy; I Kawachi
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Geographic representation of the jackson heart study cohort to the African-American population in Jackson, Mississippi.

Authors:  Demarc A Hickson; Lance A Waller; Samson Y Gebreab; Sharon B Wyatt; James Kelly; Donna Antoine-Lavigne; Daniel F Sarpong
Journal:  Am J Epidemiol       Date:  2010-11-12       Impact factor: 4.897

3.  The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseases.

Authors:  E F Monteiro; C J N Lacey; D Merrick
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

4.  Comparative geographic concentrations of 4 sexually transmitted infections.

Authors:  Roxanne P Kerani; Mark S Handcock; H Hunter Handsfield; King K Holmes
Journal:  Am J Public Health       Date:  2005-02       Impact factor: 9.308

5.  The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact.

Authors:  Gerardo Chowell; Luís M A Bettencourt; Niall Johnson; Wladimir J Alonso; Cécile Viboud
Journal:  Proc Biol Sci       Date:  2008-03-07       Impact factor: 5.349

6.  Spatial and temporal dynamics of dengue fever in Peru: 1994-2006.

Authors:  G Chowell; C A Torre; C Munayco-Escate; L Suárez-Ognio; R López-Cruz; J M Hyman; C Castillo-Chavez
Journal:  Epidemiol Infect       Date:  2008-04-08       Impact factor: 2.451

7.  Predictive Factors for Endoscopic Visibility and Strategies for Pre-endoscopic Prokinetics Use in Patients with Upper Gastrointestinal Bleeding.

Authors:  Jun Uk Lim; Jae Jun Park; Young Hoon Youn; Sunyong Kim; Jung Won Jeon; Sung Won Jung; Hyun Phil Shin; Jae Myung Cha; Kwang Ro Joo; Joung Il Lee
Journal:  Dig Dis Sci       Date:  2014-10-18       Impact factor: 3.199

8.  Inequalities in neighborhood child asthma admission rates and underlying community characteristics in one US county.

Authors:  Andrew F Beck; Terri Moncrief; Bin Huang; Jeffrey M Simmons; Hadley Sauers; Chen Chen; Robert S Kahn
Journal:  J Pediatr       Date:  2013-03-22       Impact factor: 4.406

9.  Measuring and Visualizing Chlamydia and Gonorrhea Inequality: An Informatics Approach Using Geographical Information Systems.

Authors:  Patrick T S Lai; Jeffrey Wilson; Huanmei Wu; Josette Jones; Brian E Dixon
Journal:  Online J Public Health Inform       Date:  2019-09-19

Review 10.  Seasonality in human zoonotic enteric diseases: a systematic review.

Authors:  Aparna Lal; Simon Hales; Nigel French; Michael G Baker
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.